November 6, 2024 | organ-on-a-Chip technology
Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next?
We sat down with Dr. Lorna Ewart, Chief Scientific Officer at Emulate, for a conversation about what the Liver-Chip S1’s acceptance into the FDA ISTAND Pilot Program means for the company, the drug development industry, and the future of drug safety assessment.
